Annual Retained Earnings:
-$607.06M-$116.89M(-23.85%)Summary
- As of today, AMRX annual retained earnings is -$607.06 million, with the most recent change of -$116.89 million (-23.85%) on December 31, 2024.
- During the last 3 years, AMRX annual retained earnings has fallen by -$330.87 million (-119.79%).
- AMRX annual retained earnings is now -206.46% below its all-time high of $570.22 million, reached on December 1, 2015.
Performance
AMRX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Retained Earnings:
-$572.45M+$22.42M(+3.77%)Summary
- As of today, AMRX quarterly retained earnings is -$572.45 million, with the most recent change of +$22.42 million (+3.77%) on June 30, 2025.
- Over the past year, AMRX quarterly retained earnings has increased by +$3.38 million (+0.59%).
- AMRX quarterly retained earnings is now -200.39% below its all-time high of $570.22 million, reached on December 1, 2015.
Performance
AMRX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
AMRX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -23.9% | +0.6% |
| 3Y3 Years | -119.8% | -43.4% |
| 5Y5 Years | -60.6% | -108.3% |
AMRX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -119.8% | at low | -46.2% | +5.7% |
| 5Y | 5-Year | -119.8% | at low | -115.5% | +5.7% |
| All-Time | All-Time | -206.5% | at low | -200.4% | +5.7% |
AMRX Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -$572.45M(+3.8%) |
| Mar 2025 | - | -$594.87M(+2.0%) |
| Dec 2024 | -$607.06M(-23.8%) | -$607.06M(-5.4%) |
| Sep 2024 | - | -$575.98M(-0.0%) |
| Jun 2024 | - | -$575.83M(+1.0%) |
| Mar 2024 | - | -$581.82M(-18.7%) |
| Dec 2023 | -$490.18M(-20.7%) | -$490.18M(-25.2%) |
| Sep 2023 | - | -$391.53M(+2.4%) |
| Jun 2023 | - | -$401.21M(+2.9%) |
| Mar 2023 | - | -$413.13M(-1.7%) |
| Dec 2022 | -$406.18M(-47.1%) | -$406.18M(-1.1%) |
| Sep 2022 | - | -$401.85M(-0.7%) |
| Jun 2022 | - | -$399.16M(-43.4%) |
| Mar 2022 | - | -$278.35M(-0.8%) |
| Dec 2021 | -$276.20M(+3.7%) | -$276.20M(-2.4%) |
| Sep 2021 | - | -$269.82M(-1.6%) |
| Jun 2021 | - | -$265.58M(+5.2%) |
| Mar 2021 | - | -$280.12M(+2.3%) |
| Dec 2020 | -$286.82M(+24.1%) | -$286.82M(-1.1%) |
| Sep 2020 | - | -$283.78M(-3.3%) |
| Jun 2020 | - | -$274.81M(-4.6%) |
| Mar 2020 | - | -$262.81M(+30.5%) |
| Dec 2019 | -$377.88M(-1706.3%) | -$377.88M(-9.3%) |
| Sep 2019 | - | -$345.75M(-328.2%) |
| Jun 2019 | - | -$80.75M(-26.5%) |
| Mar 2019 | - | -$63.84M(-205.2%) |
| Dec 2018 | -$20.92M(+94.5%) | -$20.92M(-72.2%) |
| Sep 2018 | - | -$12.15M(+36.4%) |
| Jun 2018 | - | -$19.10M(>-9900.0%) |
| Mar 2018 | - | $0.00(+100.0%) |
| Dec 2017 | -$382.79M(-489.8%) | -$382.79M(-489.8%) |
| Dec 2016 | $98.19M(-82.8%) | - |
| Dec 2016 | - | $98.19M(-74.0%) |
| Sep 2016 | - | $377.78M(-32.2%) |
| Jun 2016 | - | $557.11M(-0.5%) |
| Mar 2016 | - | $559.82M(-1.8%) |
| Dec 2015 | $570.22M(+7.3%) | $570.22M(+2.0%) |
| Sep 2015 | - | $558.80M(+6.8%) |
| Jun 2015 | - | $523.04M(-0.4%) |
| Mar 2015 | - | $524.89M(-1.2%) |
| Dec 2014 | $531.23M(+12.1%) | $531.23M(+0.0%) |
| Sep 2014 | - | $531.11M(+3.1%) |
| Jun 2014 | - | $515.37M(+7.3%) |
| Mar 2014 | - | $480.30M(+1.4%) |
| Dec 2013 | $473.87M(+27.2%) | $473.87M(-2.0%) |
| Sep 2013 | - | $483.50M(-0.0%) |
| Jun 2013 | - | $483.68M(+1.2%) |
| Mar 2013 | - | $478.06M(+28.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $372.61M(+17.6%) | $372.61M(+1.3%) |
| Sep 2012 | - | $367.81M(+5.8%) |
| Jun 2012 | - | $347.78M(+5.7%) |
| Mar 2012 | - | $329.11M(+3.9%) |
| Dec 2011 | $316.74M(+26.1%) | $316.74M(+7.4%) |
| Sep 2011 | - | $294.88M(+6.2%) |
| Jun 2011 | - | $277.66M(+4.7%) |
| Mar 2011 | - | $265.11M(+5.5%) |
| Dec 2010 | $251.25M(>+9900.0%) | $251.25M(+5.2%) |
| Sep 2010 | - | $238.82M(+45.9%) |
| Jun 2010 | - | $163.66M(+23.7%) |
| Mar 2010 | - | $132.31M(>+9900.0%) |
| Dec 2009 | $828.00K(+102.0%) | $828.00K(+102.2%) |
| Sep 2009 | - | -$37.32M(+15.2%) |
| Jun 2009 | - | -$44.00M(+6.4%) |
| Mar 2009 | - | -$47.01M(-13.0%) |
| Dec 2008 | -$41.59M(+31.0%) | -$41.59M(+17.9%) |
| Sep 2008 | - | -$50.65M(-21.4%) |
| Jun 2008 | - | -$41.73M(+30.8%) |
| Dec 2007 | -$60.29M(+67.6%) | -$60.29M(+67.6%) |
| Dec 2006 | -$186.22M(-6.9%) | -$186.22M(-89.5%) |
| Dec 2005 | -$174.17M(-66.6%) | - |
| Sep 2004 | - | -$98.28M(+0.7%) |
| Jun 2004 | - | -$99.01M(+0.3%) |
| Mar 2004 | - | -$99.33M(+5.0%) |
| Dec 2003 | -$104.55M(-15.7%) | -$104.55M(-5.1%) |
| Sep 2003 | - | -$99.45M(-3.8%) |
| Jun 2003 | - | -$95.84M(-2.4%) |
| Mar 2003 | - | -$93.56M(-3.6%) |
| Dec 2002 | -$90.34M(-28.5%) | -$90.34M(-4.0%) |
| Sep 2002 | - | -$86.87M(-6.4%) |
| Jun 2002 | - | -$81.66M(-7.8%) |
| Mar 2002 | - | -$75.72M(-7.7%) |
| Dec 2001 | -$70.30M(-55.6%) | -$70.30M(-10.8%) |
| Sep 2001 | - | -$63.45M(-11.9%) |
| Jun 2001 | - | -$56.68M(-12.2%) |
| Mar 2001 | - | -$50.53M(-11.8%) |
| Dec 2000 | -$45.19M(-123.4%) | -$45.19M(-14.7%) |
| Sep 2000 | - | -$39.39M(-32.3%) |
| Jun 2000 | - | -$29.77M(-20.9%) |
| Mar 2000 | - | -$24.62M(-21.7%) |
| Dec 1999 | -$20.23M(+10.5%) | -$20.23M(+17.2%) |
| Sep 1999 | - | -$24.43M(-1.2%) |
| Jun 1999 | - | -$24.14M(-3.1%) |
| Mar 1999 | - | -$23.41M(-3.6%) |
| Dec 1998 | -$22.59M | -$22.59M(-6.4%) |
| Sep 1998 | - | -$21.24M(-4.5%) |
| Jun 1998 | - | -$20.32M(-7.2%) |
| Mar 1998 | - | -$18.96M |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual retained earnings?
- What is the all-time high annual retained earnings for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual retained earnings year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly retained earnings?
- What is the all-time high quarterly retained earnings for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual retained earnings?
The current annual retained earnings of AMRX is -$607.06M
What is the all-time high annual retained earnings for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual retained earnings is $570.22M
What is Amneal Pharmaceuticals, Inc. annual retained earnings year-on-year change?
Over the past year, AMRX annual retained earnings has changed by -$116.89M (-23.85%)
What is Amneal Pharmaceuticals, Inc. quarterly retained earnings?
The current quarterly retained earnings of AMRX is -$572.45M
What is the all-time high quarterly retained earnings for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly retained earnings is $570.22M
What is Amneal Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?
Over the past year, AMRX quarterly retained earnings has changed by +$3.38M (+0.59%)